Introduction {#Sec1}
============

*Streptococcus pneumoniae* is a ubiquitous bacterium present in the commensal bacterial community in the human nasopharynx. It is responsible for non-invasive infections as well as invasive pneumococcal disease (IPD) with high morbidity and mortality especially among young children and the elderly^[@CR1]^. The introduction of the pneumococcal conjugated vaccine (PCV) provided an effective protection against IPD in children. The first PCV on the global market was Prevenar 7 (PCV-7) (Pfizer Vaccines) in 2000 including seven different serotypes (4, 6B, 9V, 14, 18C, 19F and 23F), followed by the 10-valent pneumococcal-conjugate vaccine (PCV-10) (Synflorix, GlaxoSmithKline Biologicals) in 2009 including the serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F, and by the Prevenar 13 vaccine (PCV-13) (Pfizer Vaccines) in 2010 including the serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F^[@CR1]^. Besides the conjugate vaccines, a pneumococcal polysaccharide vaccine (PPV-23) (Pneumovax®, Merck) based on purified capsular polysaccharides from 23 different serotypes, was introduced in 1996. The PPV-23 vaccine is recommended for patients older than 2 years of age and of high risk for IPD and for the 65+ years age group^[@CR2],[@CR3]^.

With the introduction of PCV, a significant reduction of IPD cases caused by the included PCV serotypes was seen, but at the same time serotype replacement was observed, with the appearance of new pneumococcal serotypes not included in the vaccines^[@CR1]^. One of the non-PCV serotypes that has emerged in recent years is serotype 24F^[@CR4],[@CR5]^. The non-vaccine serotype 24F is responsible for many penicillin non-susceptible related IPD cases^[@CR6]^. Serotype 24F is also linked to erythromycin-clindamycin and tetracycline resistance and is one of the main serotypes that was recovered from young children with IPD between 2011 and 2012 in France^[@CR7]^. After the introduction of PCV13 in 2010 in France, serotype 24F, including other non-vaccine serotypes (10A, 12F and 15A), were responsible for approximately 39% of pneumococcal meningitis (PM) cases in children below 5 years of age from 2012 to 2014^[@CR8]^.

During the last five years, a small increase of IPD cases with serotype 24F has been observed in Denmark^[@CR1]^. Because the serotype 24F is an emerging non-pneumococcal vaccine serotype, which to our knowledge is not a part of any pneumococcal vaccine or as part of planned future pneumococcal vaccine. Is it therefore essential to monitor the epidemiology and susceptibility of serotype 24F, and to provide information to the international community that measures against serotype 24F are needed.

The intention of this study was to present epidemiological data based on IPD cases in Denmark in the period from 1999 to 2016. Furthermore, to present a detailed characterization of forty-eight 24F isolates (representing 14.7% of all 24F isolates from the period) using whole-genome sequencing analysis (WGS). Thus, the serotype 24F's clonal relationship over the years and antimicrobial resistance determinants are presented. Finally, the presence of capsular, toxin and surface related genes are suggested as pneumococcal species.

Material and Methods {#Sec2}
====================

Strain collection {#Sec3}
-----------------

All invasive pneumococcal isolates of serotype 24F from 1999 to 2016 were retrieved from the Danish laboratory surveillance system at the national Neisseria and Streptococcus Reference Laboratory (NSR), Statens Serum Institut (SSI) (Supplementary Table [1](#MOESM1){ref-type="media"}). All the IPD serotype 24F cases reported were isolated form patients diagnosed with either bacteraemia (from blood) or meningitis (from cerebrospinal fluid). An IPD case was defined as the occurrence of *S. pneumoniae* in cerebrospinal fluid, blood or other normally sterile sites^[@CR9]^. Incidence and Incidence Rate Ratio (IRR) data from 24F from 1999 to 2014 was previously presented in Slotved *et al*.^[@CR1]^ including information on age, sex, serotype and origin of the pneumococcal isolate (blood, cerebrospinal fluid etc.). Data on the total IPD cases for all age groups in Denmark are presented in Fig. [1](#Fig1){ref-type="fig"} to compare with the serotype 24F. Detailed data on the total IPD cases for all age has previously been presented^[@CR1],[@CR10]^.Figure 1The IPD incidence in Denmark from 1999 to 2016. The IPD incidence for serotype 24F in all three age groups from 1999 until 2016. Red bars (left Y-axe) represent 0--4 years, green bars (left Y-axe) represent 5--64 years and blue bars (left Y-axe) represent 65+ years. The black curve (left Y-axe) represents the total serotype 24F incidences per year. The gray curve (right Y-axe) represent the total IPD incidences for all serotypes per year.

Identification of pneumococcal isolates {#Sec4}
---------------------------------------

The pneumococci isolates were phenotypically identified by optochin susceptibility and bile solubility tests^[@CR1],[@CR11]^. All isolates were serotyped either by the Quellung reaction alone or by the Pneumotest Latex kit (SSI-Diagnostica, Copenhagen, Denmark) combined with the Quellung reaction using type-specific pneumococcal rabbit-antisera as previously described (SSIDiagnostica, Copenhagen, Denmark)^[@CR11]^.

Characterization of 48 clinical selected isolates {#Sec5}
-------------------------------------------------

Forty-eight *Streptococcus pneumoniae* 24F isolates were selected for detailed characterization using whole genome sequencing (Table [1](#Tab1){ref-type="table"}). Forty-seven 24F isolates were isolated from blood and spinal fluid in the period 1999 to 2017, and one historical isolate 24F was cultured from the trachea of an eight-year-old boy in 1943. The 47 isolates were selected to represent 26 children below five years of age and 21 elderly persons above 64 years of age. Otherwise the isolates were randomly selected during the period 1999--2017 to provide a molecular picture of the serotype 24F isolates in Denmark. The isolates represent 14.7% of the total number of 24F IPD cases during  the period.Table 1Characteristics of the 47 invasive 24F isolates and one trachea 24F historical isolate from 1943.YearStrain numberAgeSexSample typeCapsular genes (Genotype)MLST (ST)PEN\* (mg/L)ERY\* (mg/L)CLI\* (mg/L)*ermB*^d^ (Tn family)*tetM*^d^ (Tn family)PBP 1aPBP 2bPBP 2x194324F-19438MaleTrachea24F7179S (0.032)S (28.22)S (25.06)NRNR00019990630-19990FemaleSpinal fluid24 Group72SSSNRNR20020021030-20021MaleBlood24F72SSSNRNR20020030373-20030FemaleBlood24 Group(12-19-2-?-6-22-14)^b^R (1.0)R (7.42)R (6.77)+(none)^c^+(Tn1545)17152220041186-20040FemaleBlood24F72S (0.047)S (27.99)S (24.08)NRNR20020041073-200475FemaleBlood24F72SSSNRNR20020050527-20050MaleSpinal fluid24F72SSSNRNR20020050741-200578MaleBlood24 Group72SSSNRNR20020060194-200686FemaleBlood24 Group72S (0.032)S (27.45)S (24.47)NRNR20020060579-200679MaleBlood24 Group72SSSNRNR20020061119-200675MaleBlood24F72SSSNRNR20020070834-20074FemaleBlood24F162S (0.047)S (29.11)S (24.59)+(none)^c^+(Tn916)202820070258-200792FemaleBlood24 Group72SSSNRNR20020071134-200783FemaleBlood24 Group72SSSNRNR20020080266-20081FemaleSpinal fluid24F11100SSSNRNR218020081108-200886FemaleBlood24 Group230I (0.75)^a^RR+(none)^c^+(Tn1545)17152220090811-20091MaleBlood24F162S (0.032)S (0.032)S (25.31)+(none)^c^+(Tn916)20120090273-200986FemaleBlood24 Group72SSSNRNR20020091199-200994MaleBlood24 Group72SSSNRNR20020100805-20101MaleSpinal fluid24F72SSSNRNR20020100510-20102MaleBlood24 Group72SSSNRNR20020100993-201088FemaleBlood24 Group72SSSNRNR20020111853-201191MaleBlood24F11131SSSNRNR00020120263-20121MaleBlood24F162SSSNRNR20020120272-201276FemaleBlood24F72SSSNRNR20020120390-201272MaleBlood24 Group72SSSNRNR20020130682-20131MaleBlood24F11100SSSNRNR218020130699-20131FemaleBlood24F4253I (0.5)R (0.0)R (0.1)+(none)^c^+(Tn1545)171511720130128-201375FemaleBlood24 Group72S (0.032)S (29.31)S (24.25)NRNR20020130366-201376MaleBlood24 Group72SSSNRNR20020140149-20141MaleSpinal24F162SSSNRNR20020140404-20141MaleBlood24 Group162S (0.03)R (0.1)R (0.1)+(none)^c^+(Tn916)202820140669-20141FemaleSpinal fluid24F11100SSSNRNR218020140747-20140FemaleBlood24 Group162S (0.03)R (0.1)R (0.1)+(none)^c^+(Tn916)202820140100-201487FemaleBlood24 Group72SSSNRNR20020150090-20151FemaleBlood24 Group72S (0.016)^a^SSNRNR20020150096-20151MaleBlood24F162S (0.032)^a^SSNRNR20020150182-20151FemaleBlood24 Group11100S (0.016)^a^SSNRNR218020150233-20151MaleSpinal fluid24 Group4253I (0.5)R (0.1)R (0.1)+(none)^c^+(Tn1545)171511620150641-20151MaleSpinal fluid24 Group162S (0.016)^a^SSNRNR20020150120-201570MaleBlood24F162S (0.016)^a^SSNRNR20020150223-201581FemaleBlood24F162S (0.03)R (0.1)R (0.1)+(none)^c^+(Tn916)202820160104-20164FemaleBlood24F72SSSNRNR20020160201-20162MaleBlood24 Group162SSSNRNR20020160041-201671FemaleBlood24 Group162SSSNRNR20020160350-201668MaleBlood24 Group162S (0.03)R (0.2)R (0.2)+(none)^c^+(Tn916)202820170068-20171FemaleBlood24F(7-11-10-1-6-?-14)^b^S (0.03)R (0.1)R (0.2)+(none)^c^+(Tn916)202820170345-20171MaleBlood24 Group162S (0.03)R (0.1)R (0.1)+(none)^c^+(Tn916)2028^\*^Isolates tagged with and S (sensitive) or R (resistance) was only tested with disk diffusion. For penicillin was S/R tagged only based on oxacillin zone diameter, penicillin test was not performed on the isolates. For isolates with an MIC value was the sensititre test performed, except for a few isolates tagged with an "a".^a^Penicillin Etest.^b^Has been submitted to the curators of the MLST database.^c^Did not harbor any mobile elements of the Tn-family^[@CR37]^.^d^NR stands for "not relevant" and tag the isolates where *ermB* and *tetM* genes were not detected and Tn linkage therefore is not relevant.

Molecular species identification {#Sec6}
--------------------------------

The isolates were sequenced by paired-end Illumina sequencing. Genomic DNA was extracted using a DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany) and fragment libraries were constructed using a Nextera XT Kit (Illumina, Little Chesterford, UK) followed by 250-bp paired-end sequencing (MiSeqTM; Illumina) according to the manufacturer's instructions. The paired-end Illumina data were de novo assembled using CLCbio's Genomics Workbench v.7.5 QIAGEN) reporting only contigs \>500 bp using standard settings.

Bioinformatics, including Blast was done using the software the CLC Main Workbench (Version 7.9.1, [www.qiagenbioinformatics.com](http://www.qiagenbioinformatics.com)).

All 48 isolates were species identified according to the description by Scholz *et al*.^[@CR12]^. Briefly, the 16S rRNA sequence (accession number: AY485600) identified by Arbique *et al*.^[@CR13]^ was used to identify the nucleotide position at 203^[@CR12]^. The *S. pneumoniae* identification was based on the location of cytosine at the 203 position, while the existence of adenine-residues suggested that the species belonged to another *Streptococcus* species^[@CR12]^.

The presence/absence of a gene was based on a cut-off of 80% coverage and a 95% identity for a positive gene detection in this study^[@CR14]^.

The genomic sequence data for the 48 isolates are deposited in the Genbank (<https://www.ebi.ac.uk/ena>) (ENA project no. PRJEB31691).

The species identification was confirmed by Multilocus Sequence Analysis (MLSA) analysis using the 9 housekeeping genes (*ddl*, *gdh*, *rpoB*, *sodA*, *map*, *pfl*, *ppaC*, *pyk*, *tuf*) as described by Bishop *et al*.^[@CR15]^ and Killian *et al*.^[@CR16]^.

Molecular characterization of their capsular genes {#Sec7}
--------------------------------------------------

Sequences from all 48 isolates were checked for the 92 capsular polysaccharide genes (CPS genes) by BLAST. The FASTA files for the capsular locus sequences were retrieved from the NCBI database, using the accession numbers CR931632-CR931722, JF911515.1 and HV580364.1^[@CR17],[@CR18]^.

Identification of serogroup/type 24F was performed according to the presence/absence of genes using a cut-off of 80% coverage and a 95% identity as described by Sheppard *et al*.^[@CR14]^ and Kapatai *et al*.^[@CR18]^. However, differentiating further into a specific serotype within the group 24 can be difficult^[@CR18]^. We therefore only presented genotypes, where the coverage and identity clearly indicated a specific genotype.

Multilocus sequence typing (MLST) {#Sec8}
---------------------------------

MLST was performed using the PubMLST DataBase (<https://pubmlst.org/spneumoniae/>) to identify the sequence type (ST) for each of the 24F *S. pneumoniae* strains. Analysis of the STs and assignment to CC was performed using PHYLOViZ 2.0 programme ([http://phyloviz.readthedocs.io/en/latest/\#](http://phyloviz.readthedocs.io/en/latest/)). The STs that shared at least six of seven allelic variants composed a CC (clonal complex)^[@CR19]^.

A phylogenetic tree based on single nucleotide polymorphisms (SNP's) analysis of the core genome was performed on the 48 isolates. Identification of SNP's' was performed using BWA-mem for mapping and GATK with filtering set to remove positions with less than 10-fold depth and 90% unambiguous variant calls as implemented in NASP^[@CR20]^ against isolate 0100-2014's chromosome, which was used as a reference strain in the SNP alignment after removal of duplicated regions using NUCmer. The resulting SNP matrix was purged for recombination using Gubbins^[@CR21]^. FigTree v1.4.3 (<http://tree.bio.ed.ac.uk/software/figtree/>, accessed 25-09-2018) was used to visualize the phylogenetic tree.

Antibiotic susceptibility testing (phenotypic tests) {#Sec9}
----------------------------------------------------

Screening of antibiotic susceptibility was performed on all 48 isolates by disk diffusion using Mueller--Hinton 5% blood agar with NAD (Oxoid, Denmark) incubated in ambient air with 5% CO~2~ at 35 °C and oxacillin, penicillin, erythromycin and clindamycin discs (Oxoid, Denmark). Some isolates were also tested using the E-test randomly, however not on a regularly basis. Isolates showing non-susceptibility were tested using a Microbroth dilution test (Sensititre, Streptococcus species MIC Plate, STP6F, Trek Diagnostic System, USA).

MIC determination of penicillin G was done by using either a gradient test (Etest; bioMérieux), before 2010, or a broth microdilution method (Sensititre, Streptococcus species MIC Plate, STP6F, Trek Diagnostic System, USA), after 2010. *S. pneumoniae* ATCC 49619 was used as a quality control strain. Interpretation of susceptibility was done according to the breakpoints described in EUCAST (<http://www.eucast.org/clinical_breakpoints/>).

We do not routinely perform phenotypical screening of tetracycline on the isolates.

Genotypic antibiotic resistance profile {#Sec10}
---------------------------------------

Penicillin (PEN) susceptibility in pneumococci is associated with penicillin-binding proteins (PBP) which in penicillin non-susceptible strains of pneumococci are modified to low-binding-affinity versions of the native PBP1A, PBP2B and PBP2X. The 48 isolates were analyzed for their PBP signature, based on a genotyping proposal and algorithm described for PBP1A, PBP2B and PBP2X^[@CR22]^, where the combination of the three PBP signatures determines the level of beta-lactam resistance. The 48 isolates were tested by BLAST with the published types of predictive mutations vs. resistance levels of PBP1A, PBP2B and PBP2X proteins as described in Li *et al*.^[@CR22]^ (Table [1](#Tab1){ref-type="table"}).

Erythromycin (ERY), clindamycin (CLI) and tetracycline (TET) genotypic profile {#Sec11}
------------------------------------------------------------------------------

The 48 *S. pneumoniae* genomes were analyzed for the genes *ermB* (NCBI, FJ667782)*, mefA* (NCBI, KU739790)*, mefE* (NCBI, NC_003098.1 (R6), and Tn916 gene *tet*(M) (FR671418)^[@CR23]^. ResFinder 2.1 (<https://cge.cbs.dtu.dk/services/ResFinder/>) (80% ID threshold and 60% minimum length settings)^[@CR24]^ was used to confirm the presence of the three genes.

Virulence gene profile {#Sec12}
----------------------

Presence of capsular, toxin and surface related genes used for pneumococcal virulence characterization^[@CR25]^ and presence of genes with potential species discrimination:

The presence of the virulence genes *lytA* and *ply*^[@CR26]^ for the identification of *S. pneumoniae* were tested as recommended by Centers for Disease Control (CDC)^[@CR12],[@CR27]^.

Genes *piaA*, *piaB* and *piaC* (GenBank: AF338658.1) coding for membrane proteins and ATP-binding proteins as previously described^[@CR14],[@CR27]^.

Genes *zmpB*^[@CR28]^ and *zmpC* (AE005672:75858-76420)^[@CR29]^, which are paralogous zinc metalloproteases^[@CR30]^.

Genes for the pneumococcal surface proteins (*pspA*) (Genbank: AF516671)^[@CR31]^ and *psrp*^[@CR32]^.

The partial capsular gene *cpsA*, also known as the *wzg* gene, was tested for its presence/absence (Genbank: AF057294:2134--2473)^[@CR33]^.

Gene *rpsB* encoding for ribosomal protein S2^[@CR29]^.

Data analysis {#Sec13}
-------------

Data were analyzed using Graph Pad Prism version 7 (GraphPad Software) for descriptive statistical analysis. RStudio version 1.1.447 and R version 3.5.0 for Windows was used for all calculations of incidence rate, incidence rate ratio (IRR) and confidence interval (CI) (<http://www.r-project.org/>). Two tailed Fisher's Exact Test in R was used to calculate P-values. P \< 0.05 was considered significant. The raw data for calculation of the incidence rate are presented in the Supplementary Table [1](#MOESM1){ref-type="media"}.

Ethical considerations {#Sec14}
----------------------

The study was a retrospective, population-based study based on national laboratory surveillance data on isolates from patients with IPD. Since data and samples from patients were collected routinely for national surveillance purposes, no ethical approval or informed consent from patients or guardians were required. The study was approved by the Danish Data Protection Agency (record number 2007-41-0229).

Results {#Sec15}
=======

Prevalence/incidence of invasive pneumococcal disease in 1999--2016 due to *S. pneumoniae* serotype 24F {#Sec16}
-------------------------------------------------------------------------------------------------------

Data from the incidence rates of serotype 24F IPD cases from 1999 until 2016 are presented in Fig. [1](#Fig1){ref-type="fig"} and Table [2](#Tab2){ref-type="table"}. The incidence of serotype 24F IPD cases was low in the period from 1999--2007 (0.22 per 100.000, CI: 0.17--0.26) and 2008--2010 (0.19 per 100.000, CI: 0.09--0.30), while an increase in incidence (0.49 per 100.000, CI: 0.29--0.69) was observed in all age groups from 2011 to 2016. The introduction of PCV-7 in 2007 did not affect the 24F incidence in any of the age groups, while the introduction of PCV-13 in 2010 showed a significant increase in prevalence, two years after the introduction. The increase in the IRR of serotype 24F IPD varied with an IRR of 3.69 (CI: 1.30-10.53) in infants (P = 0.0083), 3.78 (CI: 1.73-8.32) in the age group from 5 to 64 years ((P \< 0.001) and 1.74 (1.74 CI: 1.08--2.80) in the age group +65 (P = 0.025), although the general mean incidence was very low.Table 2The mean incidence rates and 95% confidence intervals are presented for serotype 24F for all three age groups and in total. Incidence Rate Ratios (IRRs) are calculated by dividing a mean incidence from one period by a mean incidence from another period. IRR values were statistically significant (P \< 0.01) calculated using a two tailed Fisher's Exact Test.Age1999--2007\
(Before introduction of PCV-7)2008--2010\
(After introduction of PCV-7 and before introduction of PCV-13)2011--2016\
(After introduction of PCV13)1999--2007 versus\
2008--20102008--2010 versus\
2011--2016Mean incidence of serotype 24F per 100,000\
95% confidence interval of the mean incidence (lower CI; upper CI)IRR, 95% confidence interval of the mean incidence (lower CI; upper CI)\
Two tailed Fisher's Exact Test0--4 years0.37 (0.17--0.56)0.41 (−0.03--0.85)1.53 (0.22--2.84)1.11 (0.35--3.50)\
P = 0.773.69 (1.30--10.53)\
P = 0.0083\*5--64 years0.10 (0.06--0.13)0.05 (0.02--0.09)0.21 (0.06--0.35)0.56 (0.25--1.26)\
P = 0.173.78 (1.72--8.32)\
P = 0.0002\*65 + years0.79 (0.60--0.98)0.80 (0.25--1.35)1.38 (0.53--2.23)1.01 (0.61--1.67)\
P = 11.74 (1.08--2.80)\
P = 0.025\*Total all age group0.22 (0.17--0.26)0.19 (0.09--0.30)0.49 (0.29--0.69)0.89 (0.60--1.33)\
P = 0.632.53 (1.73--3.69)\
P \< 0.00001\*

The general IPD incidence for all age groups and serotypes in Denmark was reduced since the introduction of PCV-7 (Fig. [1](#Fig1){ref-type="fig"}).

Identification of the capsular genes for serotype 24F {#Sec17}
-----------------------------------------------------

While all isolates were confirmed phenotypically to be serotype 24F, it was only possible to correctly identify the genotype to group level for 20/48 serotype 24F isolates. For the 28 remaining isolates the 24F capsular genes were correctly identified (Table [1](#Tab1){ref-type="table"}).

Phylogenetic analysis by MLST {#Sec18}
-----------------------------

The ST72 belonging to Clonal complex (CC) 72 prevailed among the others STs and included 23 isolates. This was followed by ST162 belonging to CC156 and consisting of 14 isolates.

The CC230 consisted of our isolates (1 ST230, 2 ST4253 and 1 ST(12-19-2-?-6-22-14). Three different singletons ST7179 (1 isolate), ST11100 (4 isolates) and ST4253 (2 isolates) were detected (Table [3](#Tab3){ref-type="table"}).Table 3Virulence genes detected in the *S. pneumoniae* isolates. These parameters were used for positive gene detection: *Cut-off of overlap as 80% and 95% identity. LytA*^[@CR26]^, *ply*^[@CR29]^, *piaA/piaB/piaC* (AF338658), *rpsB* (MF375925), *cpsA*/*wzg* (AF057294:2134--2473) were detected in all 48 isolates. *PspA* (AF516671) and *zmpC* (AE005672:75858--76420)^[@CR29]^ were not detected in any of the isolates.YearStrain numberMLST (ST)/Clonal Complex*psrP* ^(30)^*zmpB* ^(26)^194324F-19437179/singleton+Negative19990630-199972/72+Negative20021030-200272/72+Negative20030373-2003(12-19-2-?-6-22-14)/230NegativeNegative20041186-200472/72+Negative20041073-200472/72+Negative20050527-200572/72+Negative20050741-200572/72+Negative20060194-200672/72+Negative20060579-200672/72+Negative20061119-200672/72+Negative20070834-2007162/156Negative+20070258-200772/72+Negative20071134-200772/72+Negative20080266-200811100/singletonNegativeNegative20081108-2008230/230NegativeNegative20090811-2009162/156Negative+20090273-200972/72+Negative20091199-200972/72+Negative20100805-201072/72+Negative2010[0510-2010]{.ul}72/72+Negative20100993-201072/72+Negative20111853-201111131/singleton+Negative20120263-2012162/156Negative+20120272-201272/72+Negative20120390-201272/72+Negative20130682-201311100/singletonNegativeNegative20130699-20134253/230NegativeNegative20130128-201372/72+Negative20130366-201372/72+Negative20140149-2014162/156Negative+20140404-2014162/156Negative+20140669-201411100/singletonNegativeNegative20140747-2014162/156Negative+20140100-201472/72+Negative20150090-201572/72+Negative20150096-2015162/156Negative+20150182-201511100/singletonNegativeNegative20150233-20154253/230Negative+20150641-2015162/156Negative+20150120-2015162/156Negative+20150223-2015162/156NegativeNegative20160104-201672/72+Negative20160201-2016162/156Negative+20160041-2016162/156Negative+20160350-2016162/156Negative+20170068-2017(7-11-10-1-6-?-14)/156Negative+20170345-2017162/156Negative+

MLST sequence types correlated to clade relationships depicted in the core SNP phylogeny (Fig. [2](#Fig2){ref-type="fig"}) except for isolate 1186--2004.Figure 2SNP alignment of all 48 isolates based on their SNP site location. \*Isolate 0100-2014 was used as a reference strain in the SNP alignment. Strain number and MLST (ST) number have been added to each strain. The observed clusters of isolates contain mainly a cluster of susceptible ST72 and a cluster with cotrimoxazole-resistant ST162 isolates.

Comparison of phenotypic and genotypic antibiotic resistance profiles {#Sec19}
---------------------------------------------------------------------

BLAST results of the PBPs protein types and the 48 genomes showed that the majority of the isolates showed combinations of the three PBPs types as previously described^[@CR22]^, but several new PBP protein type combinations were also observed. The new PBPs combinations were 2-0-28, 2-18-0, 2-0-1, 0-0-0 (all penicillin susceptible) and 17-15-116/117 (both penicillin resistant). Comparison of the PBP combination with the phenotypical penicillin susceptibility (Table [1](#Tab1){ref-type="table"}), showed an agreement with the prediction in the MM model^[@CR22]^. All the penicillin non-susceptible isolates had the 17 (PBP1a) −15 (PBP2b) -X (The PBP2x showed variable numbers) signatures.

For erythromycin-clindamycin, the BLAST results in general agreed with the phenotypic antibiotic susceptibility result. The presence of the *ermB* gene was linked to the resistance of erythromycin and clindamycin. Only two isolates (0834-2007 and 0811-2009) showed different genotypic and phenotypic results. The ResFinder 2.1 search confirmed the above results (Table [1](#Tab1){ref-type="table"}). The twelve isolates harbouring the *ermB* gene also harboured the *tet(M)* gene according to ResFinder 2.1. Based on the information from the resistance gene accession number provided by the ResFinder 2.1, none of the isolates harbouring the *ermB* gene were found positive for the presence of mobile elements of Tn-family, while both Tn917 (8 isolates) and Tn1545 (4 isolates) was found in the isolates harbouring the *tet(M)* gene (Table [1](#Tab1){ref-type="table"}).

Characterization of pneumococcal virulence genes {#Sec20}
------------------------------------------------

The virulence genes *lytA* and *ply*, the combined genes *piaA*, *piaB*, and *piaC* for membrane and ATP-binding proteins, the *rpsB* gene encoding for ribosomal protein S2, and the partial capsular *cpsA* (*wzg*) gene were detected in all 48 isolates.

The zinc metalloprotease related gene *zmpB* was only detected in isolates from 2007 and forwards.

The surface protein related gene *psrp* was most commonly found in isolates before 2012. Regarding the presence of *zmpB* and *psrp*, forty-one isolates harbored only one of the genes while seven isolates did not show any of the genes, and none harbored both genes.

The pneumococcal surface protein A gene (*pspA*) and the zinc metalloprotease *zmpC* gene were absent from all isolates.

Discussion {#Sec21}
==========

With the introduction of PCV-7 in 2007 in Denmark in the children's vaccination program, a reduction in IPD with PCV-included serotypes was observed. However, as noted in other countries, non-vaccine serotypes have emerged, and it is therefore important to monitor the appearance of replacement serotypes^[@CR1],[@CR5],[@CR7],[@CR34]^. Serotype 24F has been observed to be one of the emerging non-PCV serotypes^[@CR5],[@CR7],[@CR28]^. Although serotype 24F is only among the 20 most common cause of IPD in Denmark, it is one of the serotypes which have increased most after the PCV-13 introduction in Denmark^[@CR1]^. Serotype 24F is described as a type with a high potential for invasive disease^[@CR5]^, and it is therefore an important serotype to keep under surveillance. Figure [1](#Fig1){ref-type="fig"} shows that the total incidence of 24F has been relatively steady until 2012, when a significant increase in serotype 24F IPD cases were observed with a peak in 2014 (Table [2](#Tab2){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}). In general, the total IPD in Denmark has been reduced since the introduction of the PCV (Fig. [1](#Fig1){ref-type="fig"})^[@CR1],[@CR10]^.

The analyzed MLST data show, that the majority of the isolates belong to ST72 and ST162. According to the MLST database, ST72 is a well-known clone of serotype 24F. The distribution between the previously described susceptible ST72 and resistant ST162^[@CR7]^ was also observed in this study (Table [1](#Tab1){ref-type="table"}). ST72 belonged to the penicillin susceptible lineages of CC72, while ST162 (belonging to CC156) also penicillin-susceptible was observed to be cotrimoxazole-resistant and found also among 9 V isolates^[@CR7]^. The CC156 has emerged after the PCV-13 era^[@CR7]^, which is also in accordance with our observation of the increase in ST162 (Table [1](#Tab1){ref-type="table"}). The ST162/CC156 are furthermore described as the PMEN3 clone (Spain^9V^-156), particular related to the PCV included serotype 9V and serotype 14^[@CR35]^. It has been suggested that the appearance of PMEN3 clone of serotype 14 might be due to capsular switching^[@CR35]^, which also might be the situation with the serotype 24F ST162/CC156 isolates observed in this study.

The ST162 lineage is described as a more successful lineage than the CC72 and the multidrug resistant lineage CC230^[@CR7]^ (Janoir *et al*. 2016).

Four of the 48 isolates were CC230, one ST230, two ST4253 and a new ST profile (isolate 0373-2003). As described by Janoir *et al*.^[@CR7]^, CC230 is known as a highly resistant clonal complex, which we can confirm in this study (Table [1](#Tab1){ref-type="table"}). The CC230 has previously been described in relation to a Danish penicillin resistant serotype 14, and are referred to as Denmark^[@CR14]^-32 PMEN clone. It has also been suggested that the CC230 serotype 24F might be due to capsular switching from a serotype 14 (<https://www.pneumogen.net/pmen/>, accessed 24th September 2018)^[@CR36]^. Figure [2](#Fig2){ref-type="fig"} shows that the clustering of isolates based on the SNP site location corresponded well with the MLST.

The historical trachea isolate 24F-1943 was found to harbor a new PBP signature (0-0-0)^[@CR22]^. The isolate did not show any clonal relationship with the other forty-seven 24F isolates from the period 1999--2017, and it only showed some relation to one other single isolate (isolate 1853--2011) based on the SNP site location (Fig. [2](#Fig2){ref-type="fig"}). It is well-known that capsular switching occurs regularly among pneumococcal isolates^[@CR36]^, and it is therefore a possible explanation that the 24F isolates we see today in Denmark are due to capsular switching in other serotypes^[@CR7],[@CR36]^.

In the study by Li *et al*.^[@CR22]^, penicillin susceptibility could be predicted by the signature of the three penicillin-binding proteins PBP1a, PBP2b, and PBP2x. We also found an excellent correlation between the signature of the three PBPs and the phenotypical penicillin susceptibility. Interestingly, the four penicillin non-susceptible isolates all had the 17-15-x signature, while all susceptible isolates had low-numbered PBP signatures.

Phenotypic resistance to erythromycin/clindamycin was in general agreement with the genotypic resistance and presence of relevant genes (Table [1](#Tab1){ref-type="table"}). The presence of the *ermB* gene was linked to resistance toward erythromycin and clindamycin and not to the *mefA* and *mefE* genes. The 12 isolates which were positive for the *ermB* gene, also harbored the *tetM* gene. Of note, two isolates harboring both the *ermB* gene and the *tetM* gene were erythromycin susceptible, which has been seen by others^[@CR37]^.

The selection of virulence genes in this study was inspired by other studies^[@CR12],[@CR14],[@CR26]--[@CR33]^. A more comprehensive list of various pneumococcal genes can be found in the study by Gámez *et al*.^[@CR25]^. The virulence genes (*lytA*, *ply*, the combined genes *piaA*, *piaB* and *piaC*, and the *cpsA* (*wzg*)), were detected in all 48 isolates, thus confirming their common use for identification of *S. pneumoniae* species using molecular tests^[@CR14],[@CR26],[@CR29],[@CR38]^ (Table [3](#Tab3){ref-type="table"}).

An interesting observation was made regarding the two genes *pdrp* and *zmpB* (Table [3](#Tab3){ref-type="table"}). None of the 48 isolates harbored both the *psrp* gene and the *zmpB* gene; most of the isolates had only one of the genes, while for seven isolates the two genes were absent. Interestingly, *psrp* was detected in the isolates before 2012. The *psrp* gene has been described as a gene found primarily in antibiotic susceptible strains^[@CR36]^, which we also observed. Only the MLST ST7179 and the well-known susceptible MLST ST72 strain harbored the *psrp* gene (Table [3](#Tab3){ref-type="table"}). Although the zinc metalloprotease related gene *zmpB* is described as being widespread in *S. pneumoniae*^[@CR30]^, we only detected the gene in Danish isolates from 2007 and onwards. The *zmpB* gene was only detected in the non-susceptible strains, particularly in ST162 (Table [3](#Tab3){ref-type="table"}). We have not been able to find any studies showing that the *zmpB* gene is linked to antibiotic susceptibility. A 24F isolate with the *zmpB* gene was first detected in 2007 and became more common in the 24F isolates with the increase in the 24F incidence in 2013 (Fig. [1](#Fig1){ref-type="fig"}).

Conclusion {#Sec22}
==========

We have seen an increase in serotype 24F IPD in Denmark after the introduction of the PCV-13 vaccine in 2010. It was not significantly associated with an increase in antibiotic resistance or virulence determinants, but was observed in parallel with an increase of the ST162 clone.
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